此页面是自动翻译的，不保证翻译的准确性。请参阅英文版对于源文本。

搜索临床试验以：IPSS-R intermediate risk

总计10000个结果

China National Center for Cardiovascular Diseases

未知

中间冠状动脉病变进展的危险因素

冠状动脉造影 | 冠状动脉粥样硬化

中国
Hamlet Pharma AB

尚未招聘

A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

膀胱肿瘤 | 非肌肉浸润性膀胱癌 (NMIBC)

捷克语
NYU Langone Health

招聘中

Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

前列腺癌

美国
Regina Elena Cancer Institute

招聘中

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy (62SPECIAL)

局部前列腺癌

意大利
The First Affiliated Hospital of Xiamen University

招聘中

Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL

DLBCL - 弥漫性大 B 细胞淋巴瘤 | 第一行 | Intermediate-High Risk

中国

这是预览

登录或创建免费账户，即可查看所有匹配的试验并使用完整搜索功能。

订阅